Is Argenx SE (ARGX) the Best Growth Stock to Buy According to Billionaires?
From Yahoo Finance: 2025-04-14 14:03:00
- The stock market has seen a rollercoaster ride with a 19% decrease in the S&P 500 from its all-time high. Fundstrat’s Tom Lee believes there’s an opportunity for stocks to rebound pending tariff de-escalation, despite current market pessimism towards a possible recession.
- Argenx SE (NASDAQ:ARGX) is a biopharmaceutical company focused on developing antibody therapy for autoimmune diseases. With 3-year sales growth of 62.05%, 47 hedge fund holders, and 9 billionaire investors, it’s considered one of the best growth stocks to buy. Recent positive developments include FDA approval for a new treatment.
- Argenx SE (NASDAQ:ARGX) ranks 8th on the list of best growth stocks to buy according to billionaires. While AI stocks are seen as more promising for higher returns within a shorter time frame, Argenx still holds potential for growth. Consider exploring the potential of AI stocks for significant gains.
Read more: Is Argenx SE (ARGX) the Best Growth Stock to Buy According to Billionaires?